US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Binah Capital Group Inc

2.01

+0.01000.50%

Post-market: 2.010.00000.00%16:00 EDT

Volume:5.86K

Turnover:11.47K

Market Cap:33.37M

PE:-6.58

High:2.01

Open:1.95

Low:1.93

Close:2.00

Loading ...

Overview Company News Filings

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

Altice USA to Present at the 2025 New Street Research and BCG Future of Connectivity Leaders Conference

Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support

ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage

MT Newswires Live

Transcript: Philipp Carlsson-Szlezak, BCG

The Big Picture

Press Release: enGene Reports First Quarter 2025 Financial Results and Provides Business Update

Liberty Global to Present at the NewStreet Research and BCG Future of Connectivity Leaders Conference

More Women Step Into Leadership Roles in Ultrawealthy Families -- Barrons.com

MiB: Philipp Carlsson-Szlezak, Global Chief Economist for BCG

The Big Picture

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer

Trump tariffs on North America hint at first stirrings of what’s to hit South-east Asia

Is Western Digital Corporation (WDC) the Best Performing Data Center Stock So Far In 2025?

Is Super Micro Computer, Inc. (SMCI) the Best Performing Data Center Stock So Far In 2025?

Is GDS Holdings Limited (GDS) the Best Performing Data Center Stock So Far In 2025?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCG\",,,,,undefined,":{"symbol":"BCG","market":"US","secType":"STK","nameCN":"Binah Capital Group Inc","latestPrice":2.01,"timestamp":1743105600000,"preClose":2,"halted":0,"volume":5859,"hourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2.01,"latestTime":"16:00 EDT","volume":10,"amount":20.099999999999998,"timestamp":1743105601654},"delay":0,"floatShares":4546841,"shares":16602460,"eps":-0.305436,"marketStatus":"Post-Market Trading","change":0.01,"latestTime":"03-27 18:25:48 EDT","open":1.95,"high":2.01,"low":1.9264,"amount":11465.9211,"amplitude":0.0418,"askPrice":2.01,"askSize":318,"bidPrice":1.89,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-0.305436,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743120000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2,"postHourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2.01,"latestTime":"16:00 EDT","volume":10,"amount":20.099999999999998,"timestamp":1743105601654},"volumeRatio":0.170856},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCG\",,,,,undefined,":{"symbol":"BCG","floatShares":4546841,"roa":"-6.50%","roe":"-36.81%","lyrEps":0.430802,"volumeRatio":0.170856,"shares":16602460,"dividePrice":0,"high":2.01,"amplitude":0.0418,"preClose":2,"low":1.9264,"week52Low":1.71,"pbRate":"27.29","psRate":"0.21","week52High":16.61,"institutionHeld":0,"latestPrice":2.01,"committee":-0.9875,"eps":-0.305436,"divideRate":0,"volume":5859,"delay":0,"ttmEps":-0.305436,"open":1.95,"prevYearClose":2.94,"prevWeekClose":2.14,"prevMonthClose":2.4,"prevQuarterClose":2.94,"fiveDayClose":1.87,"twentyDayClose":2.87,"sixtyDayClose":2.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCG\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521747112","title":"Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747112","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747112?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"– Latest BOND-003 data show 75.5% of patients achieved a complete response at any time –– Median duration of response exceeds 28 months and is ongoing –– No close contact precautions needed post creto","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047782/0/en/Cretostimogene-Grenadenorepvec-Data-Continues-to-Demonstrate-Best-in-Class-Durability-of-Response-as-well-as-Consistent-and-Compelling-Safety-and-Efficacy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCG","BK4161","CR","BK4135","CGON","BK4139"],"gpt_icon":0},{"id":"2521746200","title":"Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746200","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746200?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity and Urothelial Field Effect Favorable Safety P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047703/0/en/Positive-Data-from-Phase-1-Trial-of-Bel-sar-in-Patients-with-Non-Muscle-Invasive-Bladder-Cancer-NMIBC-Presented-at-the-40th-Annual-European-Association-of-Urology-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4531","LU0359201612.USD","BK4563","LU2039709279.SGD","IE00BYQNZ168.SGD","BK4097","BK4548","BK4571","01698","IE00B12V2V27.USD","LU0359202008.SGD","SG9999011746.SGD","BK4565","BK4509","LU1023057109.AUD","IE00BYTNYN87.SGD","TLS","BK4139","BK4552","BK4535","BCG","BK4108","BK4526","AURA"],"gpt_icon":1},{"id":"2521423255","title":"Altice USA to Present at the 2025 New Street Research and BCG Future of Connectivity Leaders Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2521423255","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521423255?lang=en_us&edition=fundamental","pubTime":"2025-03-22 02:47","pubTimestamp":1742582820,"startTime":"0","endTime":"0","summary":"NEW YORK, March 21, 2025----Altice USA  today announces that Dennis Mathew, Chairman and CEO, will present at the New Street Research and BCG Future of Connectivity Leaders Conference on Wednesday, March 26, 2025, at 11:35 a.m. Eastern Time. A live webcast will be available online on the Altice USA investor relations website or by following this link.Date: Wednesday, March 26, 2025Time: 11:35 a.m. Eastern TimePresenter: Dennis Mathew, Chairman & CEO. About Altice USAAltice USA  is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising services to approximately 4.6 million residential and business customers across 21 states through its Optimum brand. We operate Optimum Media, an advanced advertising and data business, which provides audience-based, multiscreen advertising solutions to local, regional and national businesses and advertising clients. We also operate News 12, wh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/altice-usa-present-2025-street-184700758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","ATUS","BCG","BK4100","BK4561"],"gpt_icon":0},{"id":"2520183637","title":"Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183637","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183637?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385600,"startTime":"0","endTime":"0","summary":"Data to be featured during oral presentation at the American Society for Parenteral and Enteral Nutrition 2025 Nutrition Science & Practice Conference. Dosing of first patient in THRIVE-3 registrational trial of IV Choline Chloride in patients dependent on parenteral support expected in 1H 2025. NEW YORK, March 19, 2025  -- Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that data from THRIVE-1, a prospective, observational study evaluating the prevalence of choline deficiency and liver injury in patients dependent on parenteral support , will be featured during an oral session at the American Society for Parenteral and Enteral Nutrition  2025 Nutrition Science & Practice Conference, taking place March 22 through March 25, 2025 in Columbus, Ohio.The Company plans to initiate THRIVE-3, a registrational Phase 3 clinical trial, in the first half of 2025. THRIVE-3 is a seamless Phase 2b/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protara-therapeutics-announces-encore-presentation-120000672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","TARA","BK4135","BCG","THAC"],"gpt_icon":0},{"id":"2519323588","title":"ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage","url":"https://stock-news.laohu8.com/highlight/detail?id=2519323588","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519323588?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:35","pubTimestamp":1741872914,"startTime":"0","endTime":"0","summary":"ImmunityBio  said Thursday that US Urology Partners has begun administering its recombinant Bacillus Calmette-Guerin, or rBCG, in the US as part of an effort to address a shortage of Tice BCG.The company said the shortage of Tice BCG is a \"significant impediment\" to treating bladder cancer.ImmunityBio said the US Food and Drug Administration recently authorized ImmunityBio's Expanded Access Program for rBCG, and 60 urology centers are preparing to launch the treatment.The company said it is working with the Serum Institute of India to produce rBCG.Price: 2.84, Change: -0.03, Percent Change: -1.05","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4135","IBRX","BK4139","BCG"],"gpt_icon":0},{"id":"2518406407","title":"Transcript: Philipp Carlsson-Szlezak, BCG","url":"https://stock-news.laohu8.com/highlight/detail?id=2518406407","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518406407?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:30","pubTimestamp":1741696203,"startTime":"0","endTime":"0","summary":"The transcript from this week’s, MiB: Philipp Carlsson-Szlezak, Global Chief Economist for BCG, is below.You can stream and download our full conversation, including any podcast extras, on Apple Podcasts, Spotify,YouTube, and Bloomberg. All of our earlier podcasts on your favorite pod hosts can be found here.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2025/03/transcript-philipp-carlsson-szlezak-bcg/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"2518200184","title":"Press Release: enGene Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200184?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:05","pubTimestamp":1741637100,"startTime":"0","endTime":"0","summary":"Additional preliminary data from ongoing LEGEND study of detalimogene in BCG-unresponsive NMIBC with CIS, including pivotal cohort, anticipated in 2H 2025. Biologics License Application  filing planned for mid-2026 remains on track. Cash and marketable securities of $272.8 million expected to provide runway into 2027. enGene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced its financial results for the first quarter ended January 31, 2025, and provided a business update.LEGEND study now includes maintenance dosing: The amended LEGEND protocol allows patients from all cohorts who are in complete response at 12 months to continue receiving detalimogene on a dose-reduced maintenance schedule throughout their second year of treatment. At the end of year two, patients may elect to remain on maintenance therapy for another year, for a total of three years of therapy. Maintenance treatment consists of two instillations of detalimogene per three-month cycl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BCG","BK4139","R","BK4022","BK4135","ENGN"],"gpt_icon":0},{"id":"2518552788","title":"Liberty Global to Present at the NewStreet Research and BCG Future of Connectivity Leaders Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2518552788","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518552788?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:01","pubTimestamp":1741636860,"startTime":"0","endTime":"0","summary":"Liberty Global  is a dynamic team of operators and investors generating and delivering shareholder value through the strategic management of three platforms — Liberty Telecom, Liberty Growth and Liberty Services.Liberty Telecom is a world leader in converged broadband, video and mobile communications services, delivering next-generation products through advanced fiber and 5G networks. Liberty Telecom currently provides approximately 80 million* connections through some of Europe’s best-known consumer brands, including Virgin Media O2  in the U.K., VodafoneZiggo in the Netherlands, Telenet in Belgium and Virgin Media in Ireland. With our substantial scale and commitment to innovation, we are building Tomorrow’s Connections Today, investing in the infrastructure and platforms that empower our customers to make the most of the digital revolution, while deploying the advanced technologies that nations and economies need to thrive.Liberty Global Ltd. is listed on the Nasdaq Global Select Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liberty-global-present-newstreet-research-200100511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCG","BK4559","BK4089","LBTYA","LBTYB","LBTYK","BK4135"],"gpt_icon":0},{"id":"2518720874","title":"More Women Step Into Leadership Roles in Ultrawealthy Families -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720874","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720874?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:10","pubTimestamp":1741626600,"startTime":"0","endTime":"0","summary":"When Merrill clients Carmen and Elijah launched a start-up more than 26 years ago, they never dreamed it would expand globally and achieve extraordinary success. They are now the parents of three young adult children, with their eldest recently expressing interest in joining the business.While Carmen joined annual reviews with their private wealth advisor and had been involved in a meeting with their trust and estate attorney years back, Elijah had taken the reins on a majority of the financial and legal planning decisions. They had not communicated any details regarding the family's wealth with their children, partially due to a fear of impeding their children's motivations. But when Elijah had a heart attack two years ago, Carmen recognized that there were major gaps in the family's planning and communication.Clarify intent: Our experience in working with clients, as backed by research, underscores that it is critical to start with the question \"Why?\" By first taking the time to unde","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCG","BK4135"],"gpt_icon":0},{"id":"2517414289","title":"MiB: Philipp Carlsson-Szlezak, Global Chief Economist for BCG","url":"https://stock-news.laohu8.com/highlight/detail?id=2517414289","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517414289?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:00","pubTimestamp":1741366835,"startTime":"0","endTime":"0","summary":"This week, I speak withPhilipp Carlsson, Global Chief Economist forBoston Consulting Group. Prior to this role at BCG, Philipp advised financial institutions and governments at the Organization for Economic Co-operation and Development  as well as McKinsey & Company. He was also Chief Economist at Stanford C. Bernstein. He is a frequent contributor to Harvard Business Review and World Economic Forum. Philipp also leads the Center for Macroeconomics at the BCG Henderson Institute.He discuss structural changes to the global economy, doomsaying, and his book “Shocks, Crises, and False Alarms: How to Assess True Macroeconomic Risk,”Be sure to check out ourMasters in Business next week with Stephanie Kelton, professor of economics and public policy at Stony Brook University and a Senior Fellow at the Schwartz Center for Economic Policy Analysis. Previously, she was Chief Economist on the U.S. Senate Budget Committee, and was named by Politico as one of the 50 people most influencing the pol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2025/03/mib-philipp-carlsson-szlezak/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["BCG","BK4135"],"gpt_icon":0},{"id":"2517892177","title":"Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2517892177","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517892177?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:15","pubTimestamp":1741209300,"startTime":"0","endTime":"0","summary":"McKemey joins Certara to accelerate growth of its strategic drug development solutions. Adrian joins Certara after serving as head of Enterprise Transformation at IQVIA and Senior Vice President and Head of the R&D Strategy Solutions at Quintiles. He has over 25 years of experience in research and development roles where he focused on business transformation, portfolio management and R&D strategies. Before IQVIA, he was a Principal with the Boston Consulting Group  working in the Life Sciences practice in New York. He holds a BSc  and a PhD in High Energy Nuclear Particle Physics from the University of London.The change is part of a planned leadership transition. Patrick Smith, PharmD. will continue to support Certara’s growth in science and innovation as Senior Vice President of Translational Sciences. Patrick and his leadership team successfully led and integrated the Certara services team building a unified offering of comprehensive scientific services for life sciences clients acro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/certara-appoints-dr-adrian-mckemey-211500225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","BCG","CERT","BK4167"],"gpt_icon":0},{"id":"2514368318","title":"ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514368318","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514368318?lang=en_us&edition=fundamental","pubTime":"2025-02-28 08:10","pubTimestamp":1740701400,"startTime":"0","endTime":"0","summary":"Regenerative Medicine Advanced Therapy  designation follows clinical data of Absolute Lymphocyte Count  and significant Overall Survival  correlations in QUILT trials across multiple tumor types, including third line or greater metastatic pancreatic cancer, checkpoint relapsed NSCLC, and supportive data from healthy volunteers. The reversal of lymphopenia by ImmunityBio’s IL-15 superagonist is consistent with the mechanism of action of ANKTIVA demonstrating proliferation and activation of NK cells, CD4+ T cells, CD8+ T cells and memory T cells without upregulation of suppressive T regulatory cells and approved in the ANKTIVA label. However, chemotherapy and radiation has also caused a reduction in the very cells necessary to kill cancer cells. This reduction in the lymphocytes by our standard of care also inhibits the induction of T cell memory in the absence of CD4+, CD8+ T cells. A treatment for the reversal of these adverse events of lymphopenia, induced by current standard-of-care,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunitybio-receives-fda-rmat-designation-001000822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2265009873.SGD","BK4139","IE0031619046.USD","BK4135","OS","BK4124","LU1804176565.USD","BK4230","IE00B66KJ199.SGD","IE00B19Z4B17.USD","ALC","IE00B7SZL793.SGD","BK4157","SMP","CAR","BK4534","BK4022","CPI","IBRX","BK4198","BK4097","AEIS","BCG"],"gpt_icon":0},{"id":"2514133860","title":"Trump tariffs on North America hint at first stirrings of what’s to hit South-east Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2514133860","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514133860?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"Notwithstanding short-term gains, the export-dependent region is likely to face an economic blow from a broader trade war, analysts say","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/international/trump-tariffs-north-america-hint-first-stirrings-whats-hit-south-east-asia","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/international/trump-tariffs-north-america-hint-first-stirrings-whats-hit-south-east-asia","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"2514605010","title":"Is Western Digital Corporation (WDC) the Best Performing Data Center Stock So Far In 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514605010","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514605010?lang=en_us&edition=fundamental","pubTime":"2025-02-26 02:19","pubTimestamp":1740507567,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Performing Data Center Stocks So Far in 2025.In this article, we are going to take a look at where Western Digital Corporation  stands against the other data center stocks.The rapid expansion of digital technologies and data-intensive applications, including artificial intelligence , cloud computing, and enterprise digital transformation, is driving an unprecedented surge in demand for data centers and related services. In recent years, hyperscalers—large-scale cloud service providers —have been the primary force behind the growing need for AI-ready data centers due to the immense capacity required to support large foundational models.To determine the 10 best-performing data center stocks in 2025, we conducted in-depth research to compile a list of U.S.-listed data center companies. Our process involved analyzing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/western-digital-corporation-wdc-best-181927800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","MNQmain","SQQQ","BCG","USJW.SI","QLD","LU1069347547.HKD","TQQQ","TSYW.SI","QID","BK4512","BK4585","WDCVV","LU0006061336.USD","LU0081259029.USD","NQmain","BK4588","LU1035773651.USD","USAW.SI",".IXIC","NVIW.SI","WDC","PSQ","BK4170"],"gpt_icon":1},{"id":"2514010522","title":"Is Super Micro Computer, Inc. (SMCI) the Best Performing Data Center Stock So Far In 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514010522","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514010522?lang=en_us&edition=fundamental","pubTime":"2025-02-26 02:19","pubTimestamp":1740507565,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Performing Data Center Stocks So Far in 2025.In this article, we are going to take a look at where Super Micro Computer, Inc.  stands against the other data center stocks.The rapid expansion of digital technologies and data-intensive applications, including artificial intelligence , cloud computing, and enterprise digital transformation, is driving an unprecedented surge in demand for data centers and related services. In recent years, hyperscalers—large-scale cloud service providers —have been the primary force behind the growing need for AI-ready data centers due to the immense capacity required to support large foundational models.To determine the 10 best-performing data center stocks in 2025, we conducted in-depth research to compile a list of U.S.-listed data center companies. Our process involved analyzing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/super-micro-computer-inc-smci-181925970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4170",".IXIC","BK4543","QLD","MNQmain","TQQQ","PSQ","SMCI","BK4585","BK4135","LU1861215975.USD","BK4588","LU0053671581.USD","TSYW.SI","NVIW.SI","NQmain","USAW.SI","USJW.SI","SQQQ","QID","BCG","LU1861220033.SGD"],"gpt_icon":1},{"id":"2514010546","title":"Is GDS Holdings Limited (GDS) the Best Performing Data Center Stock So Far In 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514010546","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514010546?lang=en_us&edition=fundamental","pubTime":"2025-02-26 02:19","pubTimestamp":1740507564,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Performing Data Center Stocks So Far in 2025.In this article, we are going to take a look at where GDS Holdings Limited  stands against the other data center stocks.The rapid expansion of digital technologies and data-intensive applications, including artificial intelligence , cloud computing, and enterprise digital transformation, is driving an unprecedented surge in demand for data centers and related services. In recent years, hyperscalers—large-scale cloud service providers —have been the primary force behind the growing need for AI-ready data centers due to the immense capacity required to support large foundational models.To determine the 10 best-performing data center stocks in 2025, we conducted in-depth research to compile a list of U.S.-listed data center companies. Our process involved analyzing relevan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gds-holdings-limited-gds-best-181924810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","BK4116","TQQQ","TSYW.SI","BK4607","BK4588","BK4135","BK4563","BK4585","MNQmain","PSQ","NVIW.SI","GDS","QLD","SQQQ","BK4531","BK4526","NQmain","BK4529","USJW.SI","BK4505","USAW.SI","BCG","QID"],"gpt_icon":1}],"pageSize":16,"totalPage":7,"pageCount":1,"totalSize":106}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCG\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCG\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCG","date":"2025-03-26","current":-7.916861,"percent":0.736607,"low":-94.684933,"twenty":-19.596531,"median":-11.200188,"eighty":-7.373772,"high":216.897522,"avg":4.727798,"sd":62.873136,"marketCap":34367092},"quantilePoints":[{"date":"2024-04-12","current":47.846282,"twenty":47.314657,"median":50.799756,"eighty":52.276493,"marketCap":133339024},{"date":"2024-04-19","current":40.132439,"twenty":41.297957,"median":46.73873,"eighty":50.917895,"marketCap":111841925},{"date":"2024-04-26","current":203.935518,"twenty":44.420253,"median":50.799756,"eighty":187.977853,"marketCap":116447181},{"date":"2024-05-03","current":181.468046,"twenty":45.542573,"median":118.644354,"eighty":199.211588,"marketCap":103618254},{"date":"2024-05-10","current":158.424485,"twenty":47.403261,"median":158.424485,"eighty":194.026786,"marketCap":90460381},{"date":"2024-05-17","current":135.380923,"twenty":48.08256,"median":150.76106,"eighty":191.347973,"marketCap":77302507},{"date":"2024-05-24","current":216.897522,"twenty":50.268131,"median":142.815352,"eighty":191.347973,"marketCap":123848485},{"date":"2024-05-31","current":-70.098677,"twenty":46.96024,"median":139.70159,"eighty":188.726768,"marketCap":145945446},{"date":"2024-06-07","current":-77.180156,"twenty":40.710114,"median":130.655552,"eighty":184.646906,"marketCap":160689084},{"date":"2024-06-14","current":-52.991736,"twenty":-57.718026,"median":121.266741,"eighty":182.34255,"marketCap":110328794},{"date":"2024-06-21","current":-39.863152,"twenty":-52.943996,"median":66.796341,"eighty":180.865278,"marketCap":82995083},{"date":"2024-06-28","current":-46.865063,"twenty":-56.142596,"median":53.605557,"eighty":179.659743,"marketCap":97573062},{"date":"2024-07-05","current":-45.194153,"twenty":-52.896255,"median":49.470693,"eighty":176.203209,"marketCap":94094226},{"date":"2024-07-12","current":-42.966272,"twenty":-51.448132,"median":45.631177,"eighty":169.370177,"marketCap":89455779},{"date":"2024-07-15","current":-46.626362,"twenty":-50.795682,"median":45.409667,"eighty":167.641909,"marketCap":97076086},{"date":"2024-08-02","current":-31.986002,"twenty":-50.143231,"median":45.188156,"eighty":165.913642,"marketCap":66594857},{"date":"2024-08-09","current":-28.166778,"twenty":-49.363473,"median":40.613835,"eighty":159.576663,"marketCap":58643232},{"date":"2024-08-16","current":-20.272151,"twenty":-47.35838,"median":-24.029285,"eighty":158.424485,"marketCap":59802844},{"date":"2024-08-23","current":-19.247598,"twenty":-46.674102,"median":-19.602159,"eighty":156.120128,"marketCap":56780413},{"date":"2024-08-30","current":-19.866672,"twenty":-46.24444,"median":-19.585275,"eighty":147.891273,"marketCap":58606683},{"date":"2024-09-06","current":-18.302664,"twenty":-45.957998,"median":-19.585275,"eighty":144.080444,"marketCap":53992860},{"date":"2024-09-13","current":-15.251751,"twenty":-45.448768,"median":-19.106899,"eighty":140.947095,"marketCap":44992666},{"date":"2024-09-20","current":-16.883858,"twenty":-45.194153,"median":-18.403405,"eighty":138.834001,"marketCap":49807380},{"date":"2024-09-27","current":-18.009448,"twenty":-45.194153,"median":-18.156337,"eighty":136.530797,"marketCap":53127872},{"date":"2024-10-04","current":-14.801515,"twenty":-45.098673,"median":-18.009448,"eighty":129.710478,"marketCap":43664469},{"date":"2024-10-11","current":-15.139192,"twenty":-44.271652,"median":-17.794742,"eighty":123.304944,"marketCap":44660617},{"date":"2024-10-18","current":-13.732204,"twenty":-43.642912,"median":-16.883858,"eighty":121.209133,"marketCap":40510002},{"date":"2024-10-25","current":-11.706141,"twenty":-43.204974,"median":-16.377341,"eighty":95.05469,"marketCap":34533116},{"date":"2024-10-31","current":-12.147373,"twenty":-41.725024,"median":-16.067805,"eighty":68.991477,"marketCap":35834749},{"date":"2024-11-08","current":-12.325216,"twenty":-38.781038,"median":-15.870826,"eighty":54.048578,"marketCap":36359387},{"date":"2024-11-15","current":-19.641554,"twenty":-35.089122,"median":-15.983385,"eighty":51.154173,"marketCap":57942585},{"date":"2024-11-22","current":-9.482521,"twenty":-31.222157,"median":-15.814546,"eighty":49.736506,"marketCap":41174100},{"date":"2024-11-29","current":-9.867391,"twenty":-29.805862,"median":-15.758267,"eighty":48.08256,"marketCap":42834346},{"date":"2024-12-06","current":-9.217214,"twenty":-28.707835,"median":-15.561288,"eighty":47.403261,"marketCap":40011928},{"date":"2024-12-13","current":-11.205991,"twenty":-28.548701,"median":-15.251751,"eighty":45.542573,"marketCap":48645207},{"date":"2024-12-20","current":-8.873003,"twenty":-28.103124,"median":-15.039858,"eighty":44.420253,"marketCap":38517707},{"date":"2024-12-27","current":-11.66494,"twenty":-27.84851,"median":-14.773376,"eighty":41.348639,"marketCap":50637503},{"date":"2025-01-03","current":-10.555814,"twenty":-27.84851,"median":-14.407558,"eighty":41.145913,"marketCap":45822789},{"date":"2025-01-10","current":-10.364586,"twenty":-27.132405,"median":-13.712083,"eighty":40.517556,"marketCap":44992666},{"date":"2025-01-17","current":-9.599672,"twenty":-25.795677,"median":-13.338247,"eighty":11.509386,"marketCap":41672174},{"date":"2025-01-24","current":-9.561426,"twenty":-24.74539,"median":-12.325216,"eighty":-7.572649,"marketCap":41506150},{"date":"2025-01-31","current":-8.069843,"twenty":-22.526431,"median":-12.059139,"eighty":-7.572649,"marketCap":35031190},{"date":"2025-02-07","current":-8.299318,"twenty":-20.109959,"median":-11.84684,"eighty":-7.649141,"marketCap":36027338},{"date":"2025-02-14","current":-7.955106,"twenty":-19.799137,"median":-11.755302,"eighty":-7.809773,"marketCap":34533116},{"date":"2025-02-21","current":-7.534404,"twenty":-19.697834,"median":-11.685541,"eighty":-7.672088,"marketCap":32706846},{"date":"2025-02-28","current":-10.976517,"twenty":-19.697834,"median":-11.593582,"eighty":-7.542053,"marketCap":47649060},{"date":"2025-03-07","current":-8.567038,"twenty":-19.686578,"median":-11.300169,"eighty":-7.572649,"marketCap":37189510},{"date":"2025-03-14","current":-7.381421,"twenty":-19.641554,"median":-11.255905,"eighty":-7.572649,"marketCap":32042747},{"date":"2025-03-21","current":-7.151947,"twenty":-19.630298,"median":-11.225114,"eighty":-7.350824,"marketCap":31046600},{"date":"2025-03-26","current":-7.916861,"twenty":-19.596531,"median":-11.200188,"eighty":-7.373772,"marketCap":34367092}],"updateTime":1743100798846}}}